Asked by: Selaine Saxby (Conservative - North Devon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Government announcement on investment into neurodegenerative disease research of 14 November 2021, what (a) allocation of funding is available for research into cures for Parkinson's Disease and (b) the allocation process is to determine the distribution of funds.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The £375 million investment will fund research projects into a range of neurodegenerative diseases, including Parkinson’s disease, through the National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI). The NIHR and UKRI rely on researchers submitting high-quality applications to access funding, therefore details of allocations are not currently available. All applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.
Asked by: Selaine Saxby (Conservative - North Devon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment the National Institute for Health Research has made of the merits of funding projects to establish the potential effect of microplastics on human health.
Answered by Edward Argar - Minister of State (Ministry of Justice)
The National Institute for Health Research is funding research on microplastic toxicity in humans through the Health Protection Research Unit in Environmental Exposure, which is led by Imperial College London and Public Health England. This work will be reported in peer reviewed academic journals in due course.
Asked by: Selaine Saxby (Conservative - North Devon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the disruption to routine dentistry as a result of the covid-19 outbreak on the early detection of oral cancers.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
No such assessment has been made. Dentists play an ad hoc role in detecting oral cancers as a by-product of dental check-ups. However, oral cancer is primarily detected through the medical system. Patients with concerns about changes in their mouth should seek advice from their general practitioner and not wait for their next dental appointment.
Asked by: Selaine Saxby (Conservative - North Devon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans he has to support the private dentistry sector to recover from the effect of the covid-19 outbreak.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
Dentists who meet the criteria can access the full range of HM Treasury support for their private earnings. Self-employed dentists who have met the criteria have been eligible for the Self-Employment Income Support Scheme which will continue until September, with a fourth and fifth grant. Dentists who receive a salary through a Pay As You Earn scheme may be eligible for the Coronavirus Job Retention Scheme, which has also been extended until September. In addition, a new United Kingdom-wide Recovery Loan Scheme will help businesses of all sizes through the next stage of recovery.